You are here:
Home / Centre
Details / France / Lyon
France
- Lyon
Within the Action-LADA European project we are Partner n°11 identified
with the:
Department of Endocrinology and Diabetes,
Hôpital Edouard Herriot,
Lyon France
Tel +33.(0)4.72117863,
Fax +33.(0)4.72117865
We are also identified with the Immunology of Diabetes team
at INSERM449 laboratory.
You can visit the hospital’s official website by following this
link:
http://www.chu-lyon.fr/internet/chu/etablissements/heh/presentation_heh.htm
|
| Select a country from the above map to see
details of a European Centre (full text list) |
|
| 
|
The team working on the project is headed
by Professor Charles Thivolet, Director of the Department.
The Department of Endocrinology and Diabetes is located in a hospital
of 1200 beds and has an in-patients section that visits about 1800
patients per year, and an out-patients centre that visits approximately
5000 patients per year.
|
| The division has four
senior physicians and 2 permanent residents and 2 visiting residents
operating in caring type 1 and type 2 diabetes, and endocrinopathies.
The clinic is also connected to the Immunology of Diabetes Laboratory
at INSERM449 located at Laennec Faculty at a walking distance from
the department. In the last two decades, the analysis and characterisation
of the autoimmune markers in type 1 diabetes has been among the
major research topics of the Laboratory by studying first degree
relatives of type 1 diabetic patients and an experimental model
of autoimmune diabetes, the NOD mouse. |
 |
We analysed several preventive strategies in this model including oral
tolerance with insulin alone or conjugated to mucosal adjuvants. Currently,
two senior researchers, two PhD students and three technicians participate
into ongoing research.
The initial patient enrolment for this project will also involve other
diabetology units from Lyon and immediate surroundings which encompasses
6 clinical Centres dedicated to diabetes. Since, type 2 diabetes concerns
mostly general practioners, participation of several active physicians
will be encouraged individually or through a collaborative network.
|